Copyright: ©Author(s) 2026.
World J Gastroenterol. Mar 21, 2026; 32(11): 114243
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.114243
Published online Mar 21, 2026. doi: 10.3748/wjg.v32.i11.114243
Figure 3 Vibration-controlled transient elastography.
A: Distribution across different categories of FibroScan (F), controlled attenuation parameter (S) dB/m, and kilopascals; B: Mean and SD of controlled attenuation parameter and kilopascals among participants with metabolic syndrome and those without. CAP: Controlled attenuation parameter; KPA: Kilopascals; MASLD: Metabolically dysfunction-associated steatotic liver disease.
- Citation: Hegazy M, Fathy M, Ashoush O, Abdelshafy S, Abdelfatah D, Saad S, Abd El-Moniem S, Ibrahim W, Ashraf O, Saleh S, Ahmed T, Adly R, Abdel-Wahab A, Ahmed A, Hussein S, Othman A, Abdelghani A. Egypt’s metabolic dysfunction associated steatotic liver disease: Genetic and dietary nexus, shaping artificial intelligence driven healthier future. World J Gastroenterol 2026; 32(11): 114243
- URL: https://www.wjgnet.com/1007-9327/full/v32/i11/114243.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i11.114243